PFO Closure Devices for Stroke Prevention
(OCCLUFLEX Trial)
Recruiting in Palo Alto (17 mi)
+55 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Occlutech International AB
No Placebo Group
Trial Summary
What is the purpose of this trial?
The objective of this study is to investigate whether percutaneous PFO closure with the Occlutech Flex II PFO Occluder is non-inferior to the AMPLATZER™ PFO Occluder and Gore® Cardioform Septal Occluder in closure of the PFO, prevention of recurrent embolic stroke, and device/procedure related Serious Adverse Events (SAE).
Eligibility Criteria
This trial is for adults aged 18 and over who've had a stroke of unknown cause (cryptogenic) linked to a heart condition called Patent Foramen Ovale (PFO). Participants must be able to stop anticoagulation meds, have a life expectancy over 2 years, and not have other conditions causing strokes or serious heart issues.Inclusion Criteria
I have a hole in my heart and had a stroke with an unknown cause.
You have a condition called a patent foramen ovale (PFO) that allows bubbles to pass from the right side of the heart to the left side.
I had a stroke, but doctors don't know why.
See 1 more
Exclusion Criteria
I am at least 18 years old but not older than 50.
I have a severe heart valve problem.
You have growths or artificial valves in your heart.
See 15 more
Treatment Details
Interventions
- Investigational PFO Closure Device (PFO Occluder)
- Standard of Care PFO Closure Device (PFO Occluder)
Trial OverviewThe study compares the Occlutech Flex II PFO Occluder with standard devices like the AMPLATZER™ PFO Occluder in preventing strokes by closing the PFO. It looks at how well they work and their safety by tracking Serious Adverse Events related to them.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Investigational PFO Closure DeviceExperimental Treatment1 Intervention
PFO closure with the study Occlutech Flex II PFO device.
Group II: Standard of Care PFO Closure DeviceActive Control1 Intervention
PFO closure with either of the standard of care PFO occlusion devices; Amplatzer PFO Occluder or the Gore Cardioform PFO Occluder.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
UTHealth HoustonHouston, TX
University of Texas Health Science Center at HoustonHouston, TX
Vanderbilt Medical CenterNashville, TN
Ottawa Heart InstituteOttawa, Canada
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Occlutech International ABLead Sponsor